Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$773K Hold
5,250
0.39% 64
2025
Q4
$638K Hold
5,250
0.31% 69
2025
Q3
$566K Sell
5,250
-1,000
-16% -$93.3K 0.29% 73
2025
Q2
$549K Hold
6,250
0.3% 72
2025
Q1
$425K Hold
6,250
0.24% 77
2024
Q4
$394K Hold
6,250
0.23% 74
2024
Q3
$484K Sell
6,250
-1,000
-14% -$78.5K 0.29% 68
2024
Q2
$598K Hold
7,250
0.38% 61
2024
Q1
$506K Hold
7,250
0.32% 63
2023
Q4
$421K Hold
7,250
0.29% 62
2023
Q3
$333K Hold
7,250
0.25% 66
2023
Q2
$352K Hold
7,250
0.25% 67
2023
Q1
$289K Sell
7,250
-1,500
-17% -$59.1K 0.21% 69
2022
Q4
$330K Hold
8,750
0.24% 68
2022
Q3
$265K Hold
8,750
0.21% 68
2022
Q2
$279K Hold
8,750
0.2% 73
2022
Q1
$320K Sell
8,750
-3,000
-26% -$112K 0.2% 79
2021
Q4
$505K Hold
11,750
0.3% 69
2021
Q3
$393K Hold
11,750
0.26% 71
2021
Q2
$381K Hold
11,750
0.24% 78
2021
Q1
$388K Buy
+11,750
New +$354K 0.26% 75

Other funds holding KLAC

Brooks Moore & Associates's KLAC Position: Q1 2026 in Review

Brooks Moore & Associates held its KLA (KLAC) position steady in Q1 2026 at 5,250 shares worth $773K. The position accounts for 0.39% of the portfolio, ranked #64.

Brooks Moore & Associates first reported a position in KLAC in Q1 2021 and has held it in 21 quarters since. 2,063 funds tracked by Wall St. Rank hold KLAC as of Q1 2026.

  • Brooks Moore & Associates held 5,250 shares of KLA worth $773K as of Q1 2026.
  • Brooks Moore & Associates left its KLA share count unchanged in Q1 2026.
  • KLA made up 0.39% of Brooks Moore & Associates's portfolio in Q1 2026, its #64 holding.
  • Brooks Moore & Associates first reported a position in KLA in Q1 2021 and has held it in 21 quarters since.
  • 2,063 funds tracked by Wall St. Rank held KLA as of Q1 2026.

Based on Brooks Moore & Associates's 13F filing for Q1 2026, filed 15 May 2026.